P-SUB product matrix combined with 0.2 µm pore SepraPor HFF

	CellRetention - series 31 ATF-SUBmerged P-SUB	CellMembra - series 30 TFF-Integrated P-SUB	CellRetention - series 32 ATF-External P-SUB	CellRetention - series 31 ATF-SUBmerged kit
Method / Product	ATF - series 31	TFF - series 30	ATF - series 32	ATF - series 31
250 Modular	N	N	N	pn 31-0020
300 OD76 DASbox	pn 31-0031	pn 30-0031	pn 32-0031	N
500 OD82 CellVessel	pn 31-0050	pn 30-0050	N	N
2 – OD110	pn 31-0200	N	N	N
3 – OD137	pn 31-0320	pn 30-0320	pn 32-0320	pn 31-0021
6 – OD150	N	N	N	N
13 – OD200	pn 31-1301	pn 30-1301	pn 32-1301	N
30 – OD250	pn 31-3001	ultimo 2026	Y	N

The numbers in first column refer to Vessel Volume in ml or liter. Numbers behind OD is available vessel diameter in mm. The matrix describe what’s physical possible and presently available. Check actual delivery time and price under Commerce. All products are manufactured according to order with delivery time depending on product. N refer to either not currently available or not possible, Y and non active pn numbers refer to possible and/or available on request.

We agree in this website is both extensive and comprehensive. In order to make it easier to get around we have added numbers to folders which correspond with product groups and part numbers.

----------------------------------------    

Patents granted for CellMembra™, CerPhragm™, CellRetention™ and a range of patent applications belong to Stobbe Group. Patents and applications which gives PerfuseCell Freedom-to-Operate, eliminate infringement of others IPR and give freedom to our customers. 

Any perfusion products system with a pump and two or more HFFs separated by valves is covered by granted US patent owned by Stobbe Group.

You can check out status here.